glp-1 receptor antagonist Agonists Explained for Pharmacy & Medical Students: Mechanism, Uses, and Side Effects GLP-1 Agonists For Obesity In

2019;156(8):2230-41.e11

Sobos clinic is where national trends meet safe, personalized care

About 40-50,000 patients receive GLP-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors(SGLT-2i) drugs, 84,000 were treated with dipeptidyl peptidase-4 (DPP-4) and more than 200,000 received sulfonylureas, with tracking of major adverse outcomes of all-cause mortality, heart attack, stroke, need for coronary revascularization

The vagal parasympathetic stimulation by SMT, could then release neurotrophins ( brain-derived neurotrophic factor , BNDF and nerve growth factor , NGF) to help resolve depression and related neuro-cognitive impairments 779